• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·ADVENZYMES.NS
Share

Advanced Enzyme Technologies Limited Stocks

₹ 314.25Last Updated 23.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 373.00M

₹ 314.25
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Advanced Enzyme Technologies Limited, headquartered in Thane, India, is a global company engaged in the research, development, manufacturing, and marketing of enzymes and probiotics. Its operations span India, the United States, Asia, and Europe. The company's diverse enzyme offerings cater to human healthcare, animal nutrition, and an extensive range of food processing sectors, including fruit and vegetable, baking, brewing, malting, grain, protein modification, yeast, dairy, and oils/fats processing, as well as various specialty applications. Beyond food-related uses, it also supplies industrial enzymes for non-food industries like textile processing, leather, pulp and paper production, detergents and cleaning aids, biofuels, and biocatalysis. Founded in 1957, the company was previously known as Advanced Biochemicals Limited before changing its name to Advanced Enzyme Technologies Limited in 2005.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of ADVENZYMES.NS is 370 and suggests 18.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.07.2026 15:30

Morning in New York: The news flow will set the tone for trading

24.07.2026 15:15

Google has disclosed its investments in SpaceX and Anthropic. Why is an analyst calling it an “illusion”?

24.07.2026 14:59

IPO Scribe: Shares in a biotech company backed by Eli Lilly and Sanofi are now available

24.07.2026 14:34

Cavendish Proposes Treating Halyk Bank as a Fintech Company and Raises Its Valuation by 86%

24.07.2026 14:16

Betting Against the Market: Which Stocks Is the Investor from *The Big Short* Buying in Hong Kong?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026